Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl‐2 and p53 proteins

Neuropathology and Applied Neurobiology

Volumn 21, Issue 4, 1995, Pages 352-361

  Ellison, D W ^a   Steart, P V ^a   Gatter, K C ^b   Weller, R O ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

anaplastic astrocytoma; apoptosis; astrocytoma; bcl 2; glioblastoma; p53

Indexed keywords

PROTEIN P53;

ANTIBODY LABELING; APOPTOSIS; ARTICLE; ASTROCYTOMA; CELL PROLIFERATION; CORRELATION FUNCTION; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTINUCLEAR CELL; PRIORITY JOURNAL; TUMOR GROWTH; VASCULAR ENDOTHELIUM;

ANTIBODIES, MONOCLONAL; APOPTOSIS; ASTROCYTOMA; BRAIN NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0029129839     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.1995.tb01070.x     Document Type: Article

References (46)

1. The bcZ‐2 gene is rearranged in many diffuse B‐cell lymphomas
2. Multiple subcellular localization of bcl‐2: detection in nuclear outer membrane, endoplasmic reticulum membrane, and mitochondrial membranes
3. Human gliomas with wild‐type p53 express bcl‐2
4. In situ end‐labelling detects DNA strand breaks in apoptosis and other physiological and pathological states
5. Apoptosis is inversely related to necrosis and determines net growth in tumours bearing constitutively expressed myc, ras, and HPV onco‐genes
6. Apoptosis and disease
7. Expression of the apoptosis‐suppressing protein bcl‐2, in neuroblastoma is associated with unfavorable histology and N‐myc amplification
8. Bcl‐2 blocks p53‐dependent apoptosis
9. Expression of the p53 protein in a spectrum of astrocytic tumours
10. Prevention of programmed cell death of sympathetic neurons by the bcl‐2 proto‐oncogene
11. p53 in tumour pathology: can we trust immunohistochemistry?—revisited
12. Oncogenes and cell death
13. Bcl‐2 protein is topographically restricted in tissues characterised by apoptotic cell death
14. Apoptosis. Its significance in cancer and cancer therapy
15. Actual growth rate and tumour cell proliferation in human pulmonary metastases
16. Bcl‐2 initiates a new category of oncogenes: regulators of cell death
17. The regulation of p53 function: Steiner Award Lecture
18. Expression of bcl‐2 in foetal tissues suggests a role in morphogenesis
19. Correlations between apoptotic and proliferative indices in malignant non‐Hodgkin's lymphomas
20. The p53 gene and protein in human brain tumours
21. BCL‐2 expression in adult and embryonic non‐haemopoietic tissues
22. Progression from lymphoid hyperplasia to high‐grade malignant lymphoma in mice transgenic for the t(14:18)
23. Expression of the protooncogene bcl‐2 in the prostate and its association with emergence of androgen‐independent prostate cancer
24. bcl‐2 protein expression is widespread in the developing nervous system and retained in the adult PNS
25. A study of apoptosis in normal and pathological nervous tissue after in situ end‐labelling of DNA strand breaks
26. Tumor suppressor p53 is a regulator of bcl‐2 and bax gene expression in vitro and in vivo
27. The mdm‐2 oncogene product forms a complex with the p53 protein and inhibits p53‐mediated transactivation
28. bcl‐2 protein expression in tumours of the central nervous system
29. Expression of the bcl‐2 oncogene protein is not specific for the 14;18 chromosomal translocation
30. BCL‐2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland
31. The clinical assessment of prolieration and growth in human tumours: evaluation of methods and applications as prognostic variables
32. Expression of bcl‐2 gene product in neuroblastoma
33. Differential expression of bcl‐2 protooncogene in neuroblastoma and other human tumour cell lines of neural origin
34. Amplification and overexpression of the mdm‐2 gene in a subset of human malignant gliomas without p53 mutations
35. Accumulation of wild type p53 protein in human astrocytomas
36. Tumor cell proliferation and apoptosis in medulloblastoma
37. The Bcl‐2 protein: a prognostic indicator strongly related to p53 protein in lymph node‐negative breast cancer patients
38. Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators
39. Analysis of the structure, transcripts, and protein products of bcl‐2, the gene involved in human follicular lymphoma
40. Bcl‐2 gene promotes hae‐mopoietic cell survival and cooperates with c‐myc to immortalise pre‐B cells
41. p53: a gene for all tumours
42. Programmed cell death: apoptosis and oncogenesis
43. Apoptosis (The 1992 Frank Rose Memorial Lecture)